Home
INN
INN News

Latest Summit Hotel Properties Inc. (INN) News on July 30, 2025

SUMMIT HOTEL PROPERTIES ANNOUNCES SECOND QUARTER 2025 EARNINGS RELEASE DATE

PR Newswire

a month ago

SUMMIT HOTEL PROPERTIES ANNOUNCES SECOND QUARTER 2025 EARNINGS RELEASE DATE

Argus Research

a month ago

INN: Rating increased to a HOLD

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

CNW Group

a month ago

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

CNW Group

2 months ago

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

Argus Research

2 months ago

INN: Raising target price to $4.00

Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update

CNW Group

2 months ago

Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update

Argus Research

2 months ago

INN: Rating decreased to a SELL

Argus Research

3 months ago

INN: Raising target price to $5.00

Argus Research

3 months ago

INN: What does Argus have to say about INN?

Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

CNW Group

3 months ago

Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

Summit Hotel Properties Inc (INN) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges

GuruFocus.com

3 months ago

Summit Hotel Properties Inc (INN) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges

Thomson Reuters StreetEvents

3 months ago

Q1 2025 Summit Hotel Properties Inc Earnings Call

Summit Hotel Properties (INN) Beats Q1 FFO Estimates

Zacks

3 months ago

Summit Hotel Properties (INN) Beats Q1 FFO Estimates

Associated Press Finance

3 months ago

Summit Hotel Properties: Q1 Earnings Snapshot

SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2025 RESULTS

PR Newswire

3 months ago

SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2025 RESULTS

MT Newswires

3 months ago

BofA Upgrades Summit Hotel Properties to Neutral

INN or OHI: Which Is the Better Value Stock Right Now?

Zacks

3 months ago

INN or OHI: Which Is the Better Value Stock Right Now?

SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2025 DIVIDENDS

PR Newswire

3 months ago

SUMMIT HOTEL PROPERTIES DECLARES FIRST QUARTER 2025 DIVIDENDS

Is the Options Market Predicting a Spike in Summit Hotel Properties Stock?

Zacks

3 months ago

Is the Options Market Predicting a Spike in Summit Hotel Properties Stock?

Argus Research

3 months ago

INN: What does Argus have to say about INN?

MT Newswires

3 months ago

BofA Securities Adjusts Summit Hotel Properties Price Target to $5 From $7

Argus Research

3 months ago

INN: What does Argus have to say about INN?

Innocan Pharma Announces Closing of Private Placement

CNW Group

3 months ago

Innocan Pharma Announces Closing of Private Placement

Argus Research

4 months ago

INN: Rating decreased to a HOLD

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units

CNW Group

4 months ago

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units

How Much Would It Take To Earn $100 A Month From Summit Hotel Properties Stock

Benzinga

4 months ago

How Much Would It Take To Earn $100 A Month From Summit Hotel Properties Stock

Argus Research

4 months ago

INN: Lowering target price to $6.00

SUMMIT HOTEL PROPERTIES COMPLETES $275 MILLION DELAYED DRAW TERM LOAN FINANCING

PR Newswire

4 months ago

SUMMIT HOTEL PROPERTIES COMPLETES $275 MILLION DELAYED DRAW TERM LOAN FINANCING

Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

CNW Group

4 months ago

Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2025 EARNINGS RELEASE DATE

PR Newswire

4 months ago

SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2025 EARNINGS RELEASE DATE

Argus Research

4 months ago

INN: What does Argus have to say about INN?

INN or NHI: Which Is the Better Value Stock Right Now?

Zacks

5 months ago

INN or NHI: Which Is the Better Value Stock Right Now?

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?

Zacks

5 months ago

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?

Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited

CNW Group

5 months ago

Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited

Argus Research

5 months ago

INN: Lowering target price to $7.00

Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest

CNW Group

5 months ago

Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest

INN vs. GLPI: Which Stock Is the Better Value Option?

Zacks

5 months ago

INN vs. GLPI: Which Stock Is the Better Value Option?

Should Value Investors Buy Summit Hotel Properties (INN) Stock?

Zacks

5 months ago

Should Value Investors Buy Summit Hotel Properties (INN) Stock?

Summit Hotel Properties Inc (INN) Q4 2024 Earnings Call Highlights: Strong AFFO Growth and ...

GuruFocus.com

5 months ago

Summit Hotel Properties Inc (INN) Q4 2024 Earnings Call Highlights: Strong AFFO Growth and ...

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Summit Hotel Properties Inc Earnings Call

Argus Research

5 months ago

INN: Raising target price to $8.00

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result

GuruFocus.com

5 months ago

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result

Summit Hotel Properties (INN) Q4 FFO and Revenues Beat Estimates

Zacks

5 months ago

Summit Hotel Properties (INN) Q4 FFO and Revenues Beat Estimates

Associated Press Finance

5 months ago

Summit Hotel Properties: Q4 Earnings Snapshot

SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

PR Newswire

5 months ago

SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result

GuruFocus.com

5 months ago

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q4 2024 Result

Summit Hotel Properties Announces 2025 Annual Meeting of Stockholders

PR Newswire

5 months ago

Summit Hotel Properties Announces 2025 Annual Meeting of Stockholders

Park Hotels & Resorts (PK) Q4 FFO Miss Estimates

Zacks

5 months ago

Park Hotels & Resorts (PK) Q4 FFO Miss Estimates

Argus Research

5 months ago

INN: What does Argus have to say about INN?

Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts

Insider Monkey

5 months ago

Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

CNW Group

6 months ago

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

Argus Research

6 months ago

INN: Lowering target price to $7.00

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

CNW Group

6 months ago

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

Argus Research

6 months ago

INN: What does Argus have to say about INN?

MT Newswires

6 months ago

BofA Securities Adjusts Summit Hotel Properties Price Target to $7 From $6.50

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2024 DIVIDENDS

PR Newswire

6 months ago

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2024 DIVIDENDS

Argus Research

6 months ago

INN: Raising target price to $8.00

Argus Research

6 months ago

INN: What does Argus have to say about INN?

SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE DATE

PR Newswire

7 months ago

SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE DATE

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

CNW Group

7 months ago

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60

CNW Group

7 months ago

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60

Argus Research

7 months ago

INN: Rating increased to a BUY

Innocan Pharma Announces Private Placement of Units

CNW Group

7 months ago

Innocan Pharma Announces Private Placement of Units

Argus Research

7 months ago

INN: What does Argus have to say about INN?

Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

CNW Group

8 months ago

Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

Argus Research

8 months ago

INN: What does Argus have to say about INN?

Summit Hotel Properties Announces Pending Acquisition of Two-Hotel Portfolio for $96 Million Through GIC Joint Venture

PR Newswire

8 months ago

Summit Hotel Properties Announces Pending Acquisition of Two-Hotel Portfolio for $96 Million Through GIC Joint Venture

Argus Research

8 months ago

INN: What does Argus have to say about INN?

Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs

CNW Group

8 months ago

Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs

Innocan Pharma Reports Third Quarter 2024 Financial Results

CNW Group

8 months ago

Innocan Pharma Reports Third Quarter 2024 Financial Results

How To Put $100 In Your Retirement Fund Each Month With Summit Hotel Properties Stock

Benzinga

9 months ago

How To Put $100 In Your Retirement Fund Each Month With Summit Hotel Properties Stock

Argus Research

9 months ago

INN: Rating increased to a BUY

Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand

CNW Group

9 months ago

Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...

GuruFocus.com

9 months ago

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...

Thomson Reuters StreetEvents

9 months ago

Q3 2024 Summit Hotel Properties Inc Earnings Call

Argus Research

9 months ago

INN: Lowering target price to $6.00

Summit Hotel Properties (INN) Q3 FFO and Revenues Beat Estimates

Zacks

9 months ago

Summit Hotel Properties (INN) Q3 FFO and Revenues Beat Estimates

Associated Press Finance

9 months ago

Summit Hotel Properties: Q3 Earnings Snapshot

SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2024 RESULTS

PR Newswire

9 months ago

SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2024 RESULTS

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

9 months ago

Summit Hotel Properties Inc (INN) Q3 2024 Earnings Report Preview: What To Expect

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q3 2024 Result

GuruFocus.com

9 months ago

Earnings To Watch: Summit Hotel Properties Inc (INN) Reports Q3 2024 Result

SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2024 DIVIDENDS

PR Newswire

9 months ago

SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2024 DIVIDENDS

Innocan Pharma to Present at the 2024 ThinkEquity Conference

GlobeNewswire

9 months ago

Innocan Pharma to Present at the 2024 ThinkEquity Conference

Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience

CNW Group

9 months ago

Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience

Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs

CNW Group

10 months ago

Innocan Pharma's LPT-CBD Shows Long-Term Success in Relieving Osteoarthritis Pain in Dogs

Summit Hotel Properties (INN) Shows Fast-paced Momentum But Is Still a Bargain Stock

Zacks

10 months ago

Summit Hotel Properties (INN) Shows Fast-paced Momentum But Is Still a Bargain Stock

Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide

CNW Group

10 months ago

Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Recognition Among Stanford University's List of the Top 2% Most-Cited Scientists Worldwide

Argus Research

10 months ago

INN: Rating decreased to a HOLD

Summit Hotel Properties, Inc. (INN) Hit a 52 Week High, Can the Run Continue?

Zacks

10 months ago

Summit Hotel Properties, Inc. (INN) Hit a 52 Week High, Can the Run Continue?

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?

Zacks

10 months ago

Are Investors Undervaluing Summit Hotel Properties (INN) Right Now?

SUMMIT HOTEL PROPERTIES ANNOUNCES THIRD QUARTER 2024 EARNINGS RELEASE DATE

PR Newswire

10 months ago

SUMMIT HOTEL PROPERTIES ANNOUNCES THIRD QUARTER 2024 EARNINGS RELEASE DATE

SUMMIT HOTEL PROPERTIES PUBLISHES 2024 CORPORATE RESPONSIBILITY REPORT

PR Newswire

a year ago

SUMMIT HOTEL PROPERTIES PUBLISHES 2024 CORPORATE RESPONSIBILITY REPORT

Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting

CNW Group

a year ago

Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting

Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options

CNW Group

a year ago

Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options

Argus Research

a year ago

INN: What does Argus have to say about INN?

Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration

CNW Group

a year ago

Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration

Argus Research

a year ago

INN: What does Argus have to say about INN?

Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million

CNW Group

a year ago

Innocan Pharma Reports Second Quarter 2024 Results with Revenue Growth of over 2.8X to $8.6 Million

Here Is Why Bargain Hunters Would Love Fast-paced Mover Summit Hotel Properties (INN)

Zacks

a year ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover Summit Hotel Properties (INN)

Thomson Reuters StreetEvents

a year ago

Q2 2024 Summit Hotel Properties Inc Earnings Call

Share on Social Networks: